NCT06471868View on ClinicalTrials.gov

Study to Evaluate Pharmacokinetic and Pharmacodynamic Drug Interactions and Safety of IY-HCR21 and IY-MIC

PHASE1Active, not recruitingINTERVENTIONAL

Enrollment

60

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

June 25, 2024

Study Completion Date

July 2, 2024

Conditions

Pharmacokinetics

Interventions

DRUG

IY-HCR21

Betanechol 50mg

DRUG

IY-MIC

Betanechol 25mg

Trial Locations (1)

08756

H plus Yangji Hospital, Seoul

All Listed Sponsors

lead

Il-Yang Pharm. Co., Ltd.

INDUSTRY